Literature DB >> 19209893

Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.

Pilho Kim1, Sunhee Kang, Helena I Boshoff, Jan Jiricek, Margaret Collins, Ramandeep Singh, Ujjini H Manjunatha, Pornwaratt Niyomrattanakit, Liang Zhang, Michael Goodwin, Thomas Dick, Thomas H Keller, Cynthia S Dowd, Clifton E Barry.   

Abstract

The pan class="Chemical">(S)-2-nitro-6-substituted 6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines have been extensively explored for their potential use as new antituberculars based on their excellent bactericidal properties on aerobic whole cells of pan class="Species">Mycobacterium tuberculosis. An pan class="Chemical">oxygen atom at the 2-position of the imidazole ring is required for aerobic activity. Here, we show that substitution of this oxygen by either nitrogen or sulfur yielded equipotent analogues. Acylating the amino series, oxidizing the thioether, or replacing the ether oxygen with carbon significantly reduced the potency of the compounds. Replacement of the benzylic oxygen at the 6-position by nitrogen slightly improved potency and facilitated exploration of the SAR in the more soluble 6-amino series. Significant improvements in potency were realized by extending the linker region between the 6-(S) position and the terminal hydrophobic aromatic substituent. A simple four-feature QSAR model was derived to rationalize MIC results in this series of bicyclic nitroimidazoles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19209893      PMCID: PMC2765540          DOI: 10.1021/jm801374t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

Review 1.  Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

Authors:  Alberto Matteelli; Giovanni Battista Migliori; Daniela Cirillo; Rosella Centis; Enrico Girard; Mario Raviglion
Journal:  Expert Rev Anti Infect Ther       Date:  2007-10       Impact factor: 5.091

2.  Efficient stereochemical controllers in biaryl Suzuki coupling reactions: benzylic carbinols bearing in beta-position thioether, dimethylamino, or sulfoxide groups.

Authors:  Pierre-Emmanuel Broutin; Françoise Colobert
Journal:  Org Lett       Date:  2005-08-18       Impact factor: 6.005

3.  Synthesis of (-)-tetrodotoxin: preparation of an advanced cyclohexenone intermediate.

Authors:  Douglass F Taber; Pierre H Storck
Journal:  J Org Chem       Date:  2003-10-03       Impact factor: 4.354

4.  First asymmetric total synthesis of tetrodotoxin.

Authors:  Norio Ohyabu; Toshio Nishikawa; Minoru Isobe
Journal:  J Am Chem Soc       Date:  2003-07-23       Impact factor: 15.419

5.  Total synthesis of apratoxin A.

Authors:  Jiehao Chen; Craig J Forsyth
Journal:  J Am Chem Soc       Date:  2003-07-23       Impact factor: 15.419

6.  Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7.

Authors:  Hong-yu Li; Yan Wang; Charles R Heap; Chi-Hsin R King; Sreenivasa R Mundla; Matthew Voss; David K Clawson; Lei Yan; Robert M Campbell; Bryan D Anderson; Jill R Wagner; Karen Britt; Ku X Lu; William T McMillen; Jonathan M Yingling
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

7.  Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824.

Authors:  Xiaojin Li; Ujjini H Manjunatha; Michael B Goodwin; John E Knox; Christopher A Lipinski; Thomas H Keller; Clifton E Barry; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2008-03-07       Impact factor: 2.823

8.  Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.

Authors:  M P Hay; H H Lee; W R Wilson; P B Roberts; W A Denny
Journal:  J Med Chem       Date:  1995-05-26       Impact factor: 7.446

9.  OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.

Authors:  Makoto Matsumoto; Hiroyuki Hashizume; Tatsuo Tomishige; Masanori Kawasaki; Hidetsugu Tsubouchi; Hirofumi Sasaki; Yoshihiko Shimokawa; Makoto Komatsu
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

10.  PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.

Authors:  Ramandeep Singh; Ujjini Manjunatha; Helena I M Boshoff; Young Hwan Ha; Pornwaratt Niyomrattanakit; Richard Ledwidge; Cynthia S Dowd; Ill Young Lee; Pilho Kim; Liang Zhang; Sunhee Kang; Thomas H Keller; Jan Jiricek; Clifton E Barry
Journal:  Science       Date:  2008-11-28       Impact factor: 63.714

View more
  18 in total

1.  Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.

Authors:  David F Bruhn; Michael S Scherman; Aman P Singh; Lei Yang; Jiuyu Liu; Anne J Lenaerts; Richard E Lee
Journal:  Bioorg Med Chem Lett       Date:  2015-12-07       Impact factor: 2.823

2.  Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).

Authors:  Joseph Cherian; Inhee Choi; Amit Nayyar; Ujjini H Manjunatha; Tathagata Mukherjee; Yong Sok Lee; Helena I Boshoff; Ramandeep Singh; Young Hwan Ha; Michael Goodwin; Suresh B Lakshminarayana; Pornwaratt Niyomrattanakit; Jan Jiricek; Sindhu Ravindran; Thomas Dick; Thomas H Keller; Veronique Dartois; Clifton E Barry
Journal:  J Med Chem       Date:  2011-07-26       Impact factor: 7.446

3.  Synthesis and Biological Evaluation of Polar Functionalities Containing Nitrodihydroimidazooxazoles as Anti-TB Agents.

Authors:  Kushalava Reddy Yempalla; Gurunadham Munagala; Samsher Singh; Gurleen Kour; Shweta Sharma; Reena Chib; Sunil Kumar; Priya Wazir; G D Singh; Sushil Raina; Sonali S Bharate; Inshad Ali Khan; Ram A Vishwakarma; Parvinder Pal Singh
Journal:  ACS Med Chem Lett       Date:  2015-09-11       Impact factor: 4.345

Review 4.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

5.  The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.

Authors:  Soledad Bollo; Luis J Núñez-Vergara; Sunhee Kang; Liang Zhang; Helena I Boshoff; Clifton E Barry; Juan A Squella; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2010-11-25       Impact factor: 2.823

Review 6.  Nitroimidazoles for the treatment of TB: past, present and future.

Authors:  Tathagata Mukherjee; Helena Boshoff
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

7.  Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.

Authors:  Meera Gurumurthy; Tathagata Mukherjee; Cynthia S Dowd; Ramandeep Singh; Pornwaratt Niyomrattanakit; Jo Ann Tay; Amit Nayyar; Yong Sok Lee; Joseph Cherian; Helena I Boshoff; Thomas Dick; Clifton E Barry; Ujjini H Manjunatha
Journal:  FEBS J       Date:  2011-11-14       Impact factor: 5.542

8.  Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.

Authors:  Sidharth Chopra; Gary A Koolpe; Arlyn A Tambo-Ong; Karen N Matsuyama; Kenneth J Ryan; Tran B Tran; Rupa S Doppalapudi; Edward S Riccio; Lalitha V Iyer; Carol E Green; Baojie Wan; Scott G Franzblau; Peter B Madrid
Journal:  J Med Chem       Date:  2012-06-25       Impact factor: 7.446

9.  Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824.

Authors:  Susan E Cellitti; Jennifer Shaffer; David H Jones; Tathagata Mukherjee; Meera Gurumurthy; Badry Bursulaya; Helena I Boshoff; Inhee Choi; Amit Nayyar; Yong Sok Lee; Joseph Cherian; Pornwaratt Niyomrattanakit; Thomas Dick; Ujjini H Manjunatha; Clifton E Barry; Glen Spraggon; Bernhard H Geierstanger
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

10.  Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.

Authors:  Regina Wilson; Pradeep Kumar; Vijay Parashar; Catherine Vilchèze; Romain Veyron-Churlet; Joel S Freundlich; S Whitney Barnes; John R Walker; Michael J Szymonifka; Emily Marchiano; Shubhada Shenai; Roberto Colangeli; William R Jacobs; Matthew B Neiditch; Laurent Kremer; David Alland
Journal:  Nat Chem Biol       Date:  2013-06-16       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.